RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis.
作者信息
Shubhra Quazi T H
机构信息
Institute of Chemistry, University of Silesia in Katowice, 41-500, Chorzów, Poland.
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
出版信息
Mil Med Res. 2023 Sep 12;10(1):42. doi: 10.1186/s40779-023-00480-w.
Abstract
摘要
相似文献
1
RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis.
Mil Med Res. 2023 Sep 12;10(1):42. doi: 10.1186/s40779-023-00480-w.
2
RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
Mil Med Res. 2023 Jul 25;10(1):34. doi: 10.1186/s40779-023-00470-y.
3
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
PLoS One. 2015 Sep 3;10(9):e0137204. doi: 10.1371/journal.pone.0137204. eCollection 2015.
4
Caffeic acid phenethyl ester reverses doxorubicin resistance in breast cancer cells via lipid metabolism regulation at least partly by suppressing the Akt/mTOR/SREBP1 pathway.
Kaohsiung J Med Sci. 2023 Jun;39(6):605-615. doi: 10.1002/kjm2.12675. Epub 2023 Mar 24.
5
Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids.
Biomolecules. 2020 Aug 8;10(8):1163. doi: 10.3390/biom10081163.
6
Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women.
Pathol Res Pract. 2018 May;214(5):673-678. doi: 10.1016/j.prp.2018.03.020. Epub 2018 Mar 27.
7
Lipidomic and Membrane Mechanical Signatures in Triple-Negative Breast Cancer: Scope for Membrane-Based Theranostics.
Mol Cell Biochem. 2022 Nov;477(11):2507-2528. doi: 10.1007/s11010-022-04459-4. Epub 2022 May 20.
8
NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis.
Breast Cancer Res Treat. 2021 Jun;187(2):349-362. doi: 10.1007/s10549-021-06213-8. Epub 2021 Apr 16.
9
Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis.
Sci Rep. 2017 Jul 20;7(1):6069. doi: 10.1038/s41598-017-06378-7.
10
Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma.
Life Sci. 2023 Aug 15;327:121698. doi: 10.1016/j.lfs.2023.121698. Epub 2023 Apr 18.
引用本文的文献
1
SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer.
Immunol Res. 2024 Oct;72(5):1030-1050. doi: 10.1007/s12026-024-09505-5. Epub 2024 Jun 18.
2
CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.
Cells. 2024 May 2;13(9):777. doi: 10.3390/cells13090777.
3
Deciphering the molecular interplay and tumorigenesis in hepatocellular carcinoma through insights into FBXL6 and KRAS.
Mil Med Res. 2024 Feb 8;11(1):9. doi: 10.1186/s40779-024-00515-w.
本文引用的文献
1
RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
Mil Med Res. 2023 Jul 25;10(1):34. doi: 10.1186/s40779-023-00470-y.
2
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer.
Mil Med Res. 2022 Jul 13;9(1):39. doi: 10.1186/s40779-022-00401-3.
3
Chemerin Reactivates PTEN and Suppresses PD-L1 in Tumor Cells via Modulation of a Novel CMKLR1-mediated Signaling Cascade.
Clin Cancer Res. 2020 Sep 15;26(18):5019-5035. doi: 10.1158/1078-0432.CCR-19-4245. Epub 2020 Jun 30.
4
Chemerin: at the crossroads of inflammation and obesity.
Trends Endocrinol Metab. 2010 Nov;21(11):660-7. doi: 10.1016/j.tem.2010.08.001.
Zotero 插件